Healthcare -
Biotechnology - NASDAQ - US
$ 39.24
4.39 %
$ 2.41 B
Market Cap
9.28
P/E
PTGX - NET CHANGE IN CASH
Net Change in Cash PTGX - Protagonist Therapeutics, Inc.
61 M
LAST VALUE
216.91%
2 YEAR CAGR
35.47%
5 YEAR CAGR
0.00%
10 YEAR CAGR